Midgard Science

Authera

Oslo, Norwayauthera.bioFrom their website, Nov 2026

Work here? Claim this listing

About

Authera is a pre-clinical biotechnology company focused on developing novel therapeutic biologics. It was founded in 2022 as a spin-off from Oslo University Hospital and the University of Oslo, and it works with academic institutions, non-profit organizations, life science investment firms, biotech companies, and pharmaceutical partners.

Services

  • Molecular design

    Design of novel therapeutic molecules with tailored FcRn binding and transport properties.

  • Protein engineering studies

    Comprehensive studies exploring protein engineering strategies for biologics.

  • Biochemical assays

    Biochemical assays used to understand how candidates engage FcRn.

  • Cellular assays

    Cell-based assays used to study intracellular sorting and FcRn-related properties.

  • In vivo mouse models

    Mouse model studies to reveal pharmacokinetic profiles of novel therapeutic candidates.

  • Advanced biochemical assays

    Uses biochemical assays to study how therapeutic candidates engage FcRn.

  • In vivo mouse model studies

    Uses mouse models to assess pharmacokinetic profiles of novel therapeutic candidates.

Capabilities

Assays and studies
  • Antibodies
  • PK/PD
  • In vivo
  • Rodent models
  • Biochemical assays
  • Cellular assays
Therapeutic areas
Exudative eye diseases

Modalities and species

Modalities
Antibody
Species and models
  • Mouse models
  • FcRn
  • Mouse

Industries served

  • Biotech
  • Pharmaceutical

Details

Founded
2022
Based in
Oslo, Norway

Similar labs